Metabolic processes can influence disease risk and provide therapeutic targets. By conducting
genome-wide association studies of 1,091 blood metabolites and 309 metabolite ratios, …

Aim To evaluate the cardiovascular and renal outcomes of glucagon‐like peptide‐1 receptor
agonists (GLP‐1 RAs) and the associations between these outcomes and HbA1c or weight …

Bullous pemphigoid ( BP ) is an autoimmune blistering skin disorder. Recently, BP induced
by dipeptidyl peptidase‐4 ( DPP ‐4) inhibitors has been a concern. Although DPP ‐4 …

Background Effects of antihyperglycemic therapies on cardiovascular and heart failure (HF)
risks have varied widely across cardiovascular outcome trials (CVOTs), and underlying …

Obesity is a major risk factor for Coronavirus disease (COVID-19) severity; however, the
mechanisms underlying this relationship are not fully understood. As obesity influences the …

Aims Sodium‐glucose co‐transporter 2 (SGLT2) inhibitors reduce the risk of heart failure (HF)
events regardless of diabetes status. However, factors associated with their efficacy in HF …

Context The PDX1 gene encodes pancreatic and duodenal homeobox, a critical transcription
factor for pancreatic β-cell differentiation and maintenance of mature β-cells. Heterozygous …

Gut-microbiota derived metabolites are important regulators of host biology and metabolism.
To understand the impacts of the microbial metabolite 4-cresol sulfate (4-CS) on four …

Background We have previously shown that iatrogenic dehydration is associated with a shift
to organic osmolyte production in the general ICU population. The aim of the present …

GWAS has identified thousands of loci associated with disease, yet the causal genes within
these loci remain largely unknown. Identifying these causal genes would enable deeper …